Niche eczema Soteri Skin offers a non-steroidal, non-prescription, pH-balanced eczema treatment, presenting a unique value proposition that can be leveraged to approach dermatology clinics, holistic health retailers, and direct-to-consumer channels seeking safer long-term eczema solutions.

Small team With a lean team (2-10 employees) and a modest revenue base, partnerships with contract manufacturers, co-marketing arrangements, and white-label opportunities could accelerate growth without substantial headcount expansion.

Funding readiness Recent funding of $500K signals investor confidence and potential for early-stage scaling; sales development efforts can align with near-term milestones to secure retailers, clinical endorsements, or distribution deals.

Digital presence Current tech stack and online channels (AWIN, imgix, jsDelivr, Recharge, Ruby on Rails, Facebook) indicate established e-commerce and affiliate potential; prioritize expanding affiliate networks and pharmacy or dermatologist referral partnerships.

Competitive positioning Positioning against large players with higher revenue like Neutrogena and SkinCeuticals suggests targeting specialty dermatology clinics, indie beauty retailers, and direct-to-consumer campaigns that emphasize non-steroidal safety and pH balancing for eczema.